Orchard Therapeutics 
Orchard Therapeutics is a biotechnology company incorporated in September 2015 and dedicated to bringing transformative gene therapies to patients with serious and life-threatening orphan diseases
Our programmes will use the potential of ex-vivo autologous haematopoietic stem cell gene therapy to restore normal gene function in severe and life-threatening inherited disorders
We work in partnership with the world's leading research centres to harness the life-giving potential of gene therapy
Our mission is to translate results from pre-clinical and early clinical research into commercially approved gene therapies for patients around the world
